Acinetobacter spp. - A serious enemy threatening hospitals worldwide

Macedonian Journal of Medical Sciences

Volumn 2, Issue 2, 2009, Pages 157-162

  Kurcik Trajkovska, Biljana ^a  

^a SS CYRIL AND METHODIUS UNIVERSITY OF SKOPJE   (Macedonia)

Author keywords

Acinetobacter; Hospital acquired; Multiresistance

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; BACTERIUM LIPOPOLYSACCHARIDE; BETA LACTAM; BETA LACTAMASE; CARBAPENEM; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; COLISTIN; DNA TOPOISOMERASE (ATP HYDROLYSING); POLYMYXIN B; QUINOLONE DERIVATIVE; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIBIOTIC RESISTANCE; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIUM CONTAMINATION; CYTOTOXICITY; DRUG CHOICE; GENE MUTATION; HOSPITAL INFECTION; HUMAN; IMMUNOCOMPROMISED PATIENT; MULTIDRUG RESISTANCE; NEUTROPHIL; NONHUMAN; REVIEW; TAXONOMY; TREATMENT INDICATION; URINARY CATHETER; URINARY TRACT INFECTION;

EID: 77957740117     PISSN: 18575749     EISSN: 18575773     Source Type: Journal    
DOI: 10.3889/MJMS.1857-5773.2009.0043     Document Type: Review

References (52)

1. Dijkshoorn L, van Aken E, Shunburne L, van der Reijden TJK, Bernards AT, Nemes A, Towner KJ. Prevalence of Acinetobacter baumannii and other Acinetobacter spp. in faecal samples from non-hospitalised individuals. Clinc Microbiol Infect. 2005;11:329-332. doi:10.1111/ j.1469-0691.2005.01093.x
2. Mandel AD, Wright K, McKinnon M. Selective medium for isolation of Mima and Herellea organisms. J Bacteriol. 1964;88:1524-1525.
3. Jawad A, Hawkey PM, Hertage J, Snelling AM. Description of Leeds Acinetobacter Medium, a new selective and differential medium for isolation of clinically important Acinetobacter spp., and comparison with Herellea agar and Holton's agar. J Clinc Microbiol 1994;32(10):2353-2358.
4. Seifert H, Dijkshoorn L, Gerner-Smidt P, Pelzer N, Tjernberg I, Vaneechoutte M. Distribution of Acinetobacter species on human skin: Comparison of phenotypic and genotypic identification methods. J Clin Microbiol. 1997;35(11):2819-2825.
5. Larson E L. Persistent carriage of gram-negative bacteria on hands. Am J Infect Control. 1981;9: 112-119. doi:10.1016/S0196-6553(81)80091-0
6. Webster C, Towner KJ, Humphreys H. Survival of Acinetobacter on three clinically related inanimate surfaces. Infect Control Hosp Epidemiol. 2000;21:246. doi:10.1086/503214
7. Wendt C, Dietze B, Dietz E, Ruden H. Survival of Acinetobacter baumannii on dry surfaces. J Clinic Microbiol. 1997;35(6):1394-1397.
8. Ng PC, Herrington RA, Beane CA, Ghoneim AT, Dear PR. An outbreak of Acinetobacter septicaemia in neonatal intensive care unit. J Hosp Infect. 1989;14:363-368. doi:10.1016/0195-6701(89)90077-7
9. Stone JW, Das BC. Investigation of an outbreak of infection with Acinetobacter calcoaceticus in a special care baby unit. J Hosp Infect. 1986;7(1):42-48.
10. Boujaafar N, Freney J, Bouvet PJ, Jeddi M. Cell suface hydrophobicity of 88 clinical strains of Acinetobacter baumannii. Research in Microbiology. 1990;141:477-82. doi:10.1016/0923-2508(90)90073-Y
11. Kaplan N, Rosenberg E, Jann B, Jann K. Structural studies of the capsular polysaccharide of Acinetobacter calcoaceticus BD4. Eur J Biochem. 1985;152:453-458. doi:10.1111/j.1432-1033.1985.tb09218.x
12. Rosenberg E, Kaplan N, Pines O, Rosenberg M, Gutnick D. Capsular polysaccharides interfere with adherence of Acinetobacter calcoaceticus to hydrocarbon. FEMS Microbiol Lett.. 1983;17:157-160. doi:10.1111/ j.1574-6968.1983.tb00392.x
13. Poh CL, Loh GK. Enzymatic profile of clinical isolates of Acinetobacter calcoaceticus. Med Microbiol Immunol. 1985;174:29-33. doi:10.1007/ BF02123668
14. Echenique JR, Arineti H, Tomasky ME, Read RR, Staneloni RJ, Crosa JH, Actis LA. Characterization of highaffinity iron transport system in Acinetobacter baumannii. J Bacteriol. 1992;174(23):7670-7679.
15. Smith AW, Freeman S, Minett WG, Lambert PA. Characterization of a siderophore from Acinetobacter calcoaceticus. FEMS Microbiol Lett. 1990;70:29-32. doi:10.1111/j.1574-6968.1990.tb03771.x
16. Avril JL, Mesnard R. Factors influencing the virulence of Acinetobacter, p. 77-82 In Towner KJ, Bergogne-Berezin E, Fewson CA. The biology of Acinetobacter. Plenum Publishing Corp: New York, 1991.
17. Obana Y. Patogenic significance of Acinetobacter calcoaceticus: Analysis of experimental infection in mice. Microbiol Immunol. 1986;30(7):645-657.
18. Bergogne-Berezin E, Towner KJ. Acinetobacter spp as nosocomial pathogens: Microbiological, clinical, and epidemiological features. Clin Microbiol Rev. 1996;9(2):148-165. PMID:8964033
19. Van Looveren M, Goossens H. Antimicrobial resistance of Acinetobacter spp in Europe. Clin Microbiol Infect. 2004;10:684-704. doi:10.1111/ j.1469-0691.2004.00942.x
20. Go ES, Urban C, Burns J, et al. Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet. 1994;334(8933):1329-1332. doi:10.1016/S0140-6736(94) 90694-7
21. Towner KJ, Vivian A. Plasmids capable of transfer and chromosome mobilisation in Acinetobacter calcoaceticus. J Gen Microbiol. 1977;101:167-171.
22. Seifert H, Boullion B, Schulze A, Pulverer G. Plasmid DNA profiles of Acinetobacter baumannii: Clinical application in a complex endemic setting. Infect Control Hosp Epidemiol. 1994;15(8):520-528.
23. Devaud M, Kayser FH, Bchi B. Transposon-mediated multiple antibiotic resistance in Acinetobacter strains. Antimicrob Agents Chemother. 1982;22:323-329.
24. Segal H, Thomas R, Gay EB. Characterisation of class I resistance gene cassettes and the identification of a novel IS-like element in Acinetobacter baumannii. Plasmid. 2003;49:169-178. doi:10.1016/ S0147-619X(03)00011-8
25. Poirel L, Menuteau O, Agoli N, Cattoen C, Nordmann P. Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J Clin Microbiol. 2003;41:3542-3547. doi:10.1128/JCM.41.8.3542-3547.2003
26. Koljalg S, Naaber P, Mikelsaar M. Antibiotic resistance as an indicator of bacterial chlorxedine susceptibility. J Hosp Infect. 2002;51:106-113. doi:10.1053/jhin.2002.1204
27. Fournier PE, Vallenet D, Barbe V, Audic S, Ogata H, et al. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet. 2006;2(1):e7. doi:10.1371/journal.pgen.0020007
28. Rossolini GM et al. Epidemiology of infections caused by multiresistant Gram-negatives: ESBLs, MBLs, panresistant strains. New Microbiologica. 2007;30(3):332-339.
29. Seifert H, Strate A, Pulverer G. Nosocomial bacteremia due to Acinetobacter baumannii: Clinical features, epidemiology and predictor of mortality. Medicine (Baltimore). 1995;74:340-349. doi:10.1097/ 00005792-199511000-00004
30. Villers D, Espaze E, Coste-Burel M, Giauffret F, Ninin E, Nicolas F, Richet H. Nosocomial Acinetobacer baumannii infections: Microbiological and clinical epidemiology. Ann Intern Med. 1998;129(3):182-189.
31. Bernards AT, Frenay HM, Lim BT, Hendrics WD, Dijkshoorn L, van Boven CP. Methicillin-resistant Stahylococcus aureus and Acinetobacter baumannii: an unexpected difference in epidemiologic behaviour. Am J Infect Control. 1998;26:544-551. doi:10.1053/ic.1998.v26.a84555
32. Hanberger H, Gracia Rodrigues JA, Gobernado M, Goossens H, Nilsson LE, et al. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups. JAMA. 1999;281:67-71 doi:10.1001/jama.281.1.67
33. Jones ME, Draghi DC, Thornsberry C, Karlowsky JA, Sahm DF, et al. Emerging resistance among bacterial pathogens in the intensive care unit - A European and North American Surveillance study (2000-2002). Ann Clin Microbiol Antimicrob. 2004;3:14. doi:10.1186/1476-0711-3-14
34. Hartstein AI, Rashad AL, Leibler JM, et al. Multiple intensive care units outbreak of Acinetobacter calcoaceticus subspecies anitratus respiratory infection and colonization associated with contaminated, reusable ventilator circuits and rescuciation bags. Am J Med. 1998;85(5):624-631.
35. Beck-Sague CM, JarvisWR, Bland LA, Arduing MJ, Aguero SM, Verosic G. Outbreak of gram-negative bacteremia and pyrogeic reactions in a hemodialysis center. Am J Nephrol. 1990;10(5):397-403. doi:10.1159/ 000168155
36. Weernink A, Severin WP, Tjernberg I, Dijkshoorn L. Pillows, an unexpected souse of Acinetobacter. J Hosp Infect. 1995;29:189-199. doi:10.1016/0195-6701(95)90328-3
37. Patterson JE, Vecchio J, Pantelick EL, et al. Association of contaminated glowes with transmission of Acinetobacter calcoaceticus var. anitratus in an intensive care unit. Am J Med. 1991;91:479-483. doi:10.1016/0002-9343(91)90183-X
38. Simor AE, Lee M, Vearncombe M, et al. An outbreak due to multiresitant Acinetobacter baumannii in a burn unit: Risk factors for acquisition and management Infect Control Hosp Epidemiol. 2002;23:261-267. doi:10.1086/502046
39. Torres A, Aznar R, Gatell JM, Jiminez P, Gonzales J, Ferrer A, Celis R, Rodrigues-Roisin R. Incidence risk and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis. 1990;142(3):522-528.
40. Siegman-Igra Y, Bar Yosef S, Gorea A, Avram J. Nosocomila Acinetobacter meningitis secondary to invasive procedures: Report of 25 cases and review. Clin Infect Dis. 1993;17:843-849.
41. Pedraza F, Andreu A, Saune M, Moreno A, Ramirez L, Garcia L. A urinary outbreak of Acinetobacter baumannii in a spinal cord injury unit. Ann Med Interna. 1993;10(2):55-58.
42. Nemec A, Janda L, Melter O, Dijkshoorn L. Genotypic and phenotypic similarity of multiresistant Acinetobacter baumannii isolates in the Czech Republic. J Med Microbiol. 1999;48: 287-296. doi:10.1099/ 00222615-48-3-287
43. Grundmann HJ, Towner KJ, Dijkshoorn L, et al. Multicenter study using standarzied protocols and reagents for evaluation of reproducibility of PCR-based fingerprinting of Acinetobacter spp. J Cinic Microbiol. 1997;35(12):3071-3077.
44. Levin AS, Mendes CM, Sinto SI, et al. An outbreak of multiresistant Acinetobacter baumannii in a university hospital in Sao Paulo, Brazil. Infect Control Hosp Epidemiol. 1996;17:366-368.
45. Siau H, Yuen KY, Ho PL, Wong SS, Woo PC. Acinetobacter bacteremia in Hong Kong: Prospective study and review. Clin Infec Dis. 1999;28:26-30. doi:10.1086/515068
46. Dijkshoorn L, Aucken H, Gerner-Smidt P. Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods. J Clin Microbiol. 1996;34(6):1519-25.
47. Vila J, Ruiz J, Navia M. Spread of amikacin resistance in Acinetobacter baumannii strains isolated in Spain due to epidemic strain. J Clin Microbiol. 1999;37(3):758-61.
48. Munoz-Price LS, Weinstein RA. Acinetobacter infection. The New Eng J Med. 2008;358:1271-1281. doi:10.1056/NEJMra070741
49. Buosson Y, Tran van Nhieu G, Ginot L, Bouvet P, Schill H, Driot L. Nosocomial outbreaks due to amikacin-resistant tobramycin-sensitive Acinetobacter species: Correlation with amikacin usage. J Hosp Infect. 1990;15:83-93. doi:10.1016/0195-6701(90)90024-I
50. Leonov Y, Schlaeffer F, Karpuch J, Bourvin A, Shemesh Y, Lewinson G. Ciprofloxacin in the treatment of nosocomial multiply resistant Acinetobacter calcoaceticus bacteremia. Infection. 1990;18:234-236. doi:10.1007/BF01643395
51. Jain R, Dnaziger LH. Multi-resistant acinetobacter infections: An emerging challenge to physicians. Ann Pharmacother. 2004;38:1449-1459. doi:10.1345/aph.1D592
52. Clark NM, Patterson JP, Lynch III. Antimicrobial resistance among gram-negative organism in an intensive care unit. Curr Opin Crit Care. 2003;9:413-423. doi:10.1097/00075198-200310000-00012